Evolution of neuropsychiatric symptoms in patients convalescing from COVID-19 during their hospitalization in a tertiary care center in Mexico
The database contains information about hospitalized COVID-19 patients in Mexico during 2020. It includes clinical and biochemical variables, as well as data on the severity of depressive and anxiety symptoms, information about delirium, and cognitive impairment.
Steps to reproduce
The data is classified categorically for variables reporting sociodemographic information. It is classified quantitatively for the levels of inflammatory markers, as well as for the scores obtained in the clinimetric scales that provide information about depression, anxiety, delirium, and cognitive impairment at two assessment points for the patients: upon admission and prior to hospital discharge.